2010
Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial
Nilsson KR, Al-Khatib SM, Zhou Y, Pieper K, White HD, Maggioni AP, Kober L, Granger CB, Lewis EF, McMurray JJ, Califf RM, Velazquez EJ. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart 2010, 96: 838. PMID: 20406769, DOI: 10.1136/hrt.2009.180182.Peer-Reviewed Original ResearchMeSH KeywordsAgedAnti-Arrhythmia AgentsAtrial FibrillationEpidemiologic MethodsFemaleHeart FailureHumansMaleMyocardial InfarctionStrokeVentricular Dysfunction, LeftConceptsRhythm control strategyAcute Myocardial Infarction trialMyocardial Infarction trialAtrial fibrillationMyocardial infarctionRate control strategyEarly mortalityAnti-arrhythmic drug therapyTreatment of AFPeri-infarct periodIncidence of strokeManagement of patientsRisk of deathLate mortalityPatient populationDrug therapyCox modelPatientsMortalityInfarctionStrokeValsartanTrialsDeathDays
2000
All that glitters is not gold
Velazquez E, Califf R. All that glitters is not gold. The Lancet 2000, 355: 1568-1569. PMID: 10821355, DOI: 10.1016/s0140-6736(00)02207-8.Commentaries, Editorials and Letters